hydroxyindoleacetic acid has been researched along with MPTP Neurotoxicity Syndrome in 13 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trichostatin A (TSA) was further used to study the effects of histone deacetylase inhibition on NRSF-mediated repression." | 1.42 | NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson's disease. ( Cai, L; Fei, J; Huang, D; Huang, F; Huang, L; Huang, Y; Liu, J; Ma, Y; Suo, H; Tong, J; Wang, P; Wang, Z; Xu, J; Yu, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, BC | 1 |
| Miller, DB | 1 |
| O'Callaghan, JP | 1 |
| Lu, L | 1 |
| Unger, EL | 1 |
| Alam, G | 1 |
| Williams, RW | 1 |
| Saitoh, K | 1 |
| Abe, K | 1 |
| Chiba, T | 1 |
| Katagiri, N | 1 |
| Saitoh, T | 1 |
| Horiguchi, Y | 1 |
| Nojima, H | 1 |
| Taguchi, K | 1 |
| Suo, H | 1 |
| Wang, P | 1 |
| Tong, J | 1 |
| Cai, L | 1 |
| Liu, J | 1 |
| Huang, D | 1 |
| Huang, L | 1 |
| Wang, Z | 1 |
| Huang, Y | 1 |
| Xu, J | 1 |
| Ma, Y | 2 |
| Yu, M | 1 |
| Fei, J | 1 |
| Huang, F | 1 |
| Maiti, P | 1 |
| Gregg, LC | 1 |
| McDonald, MP | 1 |
| Li, XM | 1 |
| Ma, HB | 1 |
| Ma, ZQ | 1 |
| Li, LF | 1 |
| Xu, CL | 1 |
| Qu, R | 1 |
| Ma, SP | 1 |
| Li, H | 1 |
| He, Z | 1 |
| Su, T | 1 |
| Lu, S | 1 |
| Dai, C | 1 |
| Sun, M | 1 |
| Pérez-Otaño, I | 1 |
| Luquin, MR | 1 |
| Oset, C | 1 |
| Herrero, MT | 1 |
| Kupsch, A | 1 |
| Oertel, W | 1 |
| Obeso, JA | 1 |
| Del Río, J | 1 |
| Tanila, H | 1 |
| Björklund, M | 1 |
| Riekkinen, P | 1 |
| Cheng, FC | 1 |
| Ni, DR | 1 |
| Wu, MC | 1 |
| Kuo, JS | 1 |
| Chia, LG | 1 |
| Donovan, DM | 1 |
| Miner, LL | 1 |
| Perry, MP | 1 |
| Revay, RS | 1 |
| Sharpe, LG | 1 |
| Przedborski, S | 1 |
| Kostic, V | 1 |
| Philpot, RM | 1 |
| Kirstein, CL | 1 |
| Rothman, RB | 1 |
| Schindler, CW | 1 |
| Uhl, GR | 1 |
| Bankiewicz, KS | 1 |
| Plunkett, RJ | 1 |
| Mefford, I | 1 |
| Kopin, IJ | 1 |
| Oldfield, EH | 1 |
| Russ, H | 1 |
| Mihatsch, W | 1 |
| Gerlach, M | 1 |
| Riederer, P | 1 |
| Przuntek, H | 1 |
| Bonuccelli, U | 1 |
| Garant, D | 1 |
| Fariello, R | 1 |
13 other studies available for hydroxyindoleacetic acid and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Systems analysis of genetic variation in MPTP neurotoxicity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Brain; Disease Models, Animal; Dopamine; Gene E | 2013 |
Properties of 3-methyl-TIQ and 3-methyl-N-propargyl-TIQ for preventing MPTP-induced parkinsonism-like symptoms in mice.
Topics: Animals; Antiparkinson Agents; Basal Ganglia; Behavior, Animal; Disease Models, Animal; Dopamine; Do | 2013 |
NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cell Line, Tumor; Dopamine; Drug Evaluation, Preclin | 2015 |
MPTP-induced executive dysfunction is associated with altered prefrontal serotonergic function.
Topics: Animals; Attention; Corpus Striatum; Disease Models, Animal; Dopamine; Executive Function; Hydroxyin | 2016 |
Ameliorative and neuroprotective effect in MPTP model of Parkinson's disease by Zhen-Wu-Tang (ZWT), a traditional Chinese medicine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Chromatography, High Pressure Liquid; Cor | 2010 |
Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Cell Count; Dopamine; Hydroxyindoleacetic Acid; Injections, Intraventricu | 2003 |
Neurotoxicity induced by prenatal exposure to MPTP on the monoaminergic and peptidergic systems of the marmoset brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Callithrix; Dopamine; Enkephalin, Methionine; Female | 1995 |
Cognitive changes in mice following moderate MPTP exposure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Agonists; Animals; Cerebral Cortex; Cognition; Corp | 1998 |
Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain Chemistry; Disease Models, Animal; | 1998 |
Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Ani | 1999 |
Behavioral recovery from MPTP-induced parkinsonism in monkeys after intracerebral tissue implants is not related to CSF concentrations of dopamine metabolites.
Topics: Adrenal Medulla; Amnion; Animals; Brain Tissue Transplantation; Caudate Nucleus; Disease Models, Ani | 1990 |
Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amin | 1991 |
The acute convulsant effect of MPTP is dependent on intracerebral MPP+.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemist | 1991 |